share_log

FendX to Conduct Third Pilot Run on Dunmore's Commercial Manufacturing Line for Further Development of REPELWRAP(TM) Film

FendX to Conduct Third Pilot Run on Dunmore's Commercial Manufacturing Line for Further Development of REPELWRAP(TM) Film

FendX 將在鄧莫爾的商業生產線上進行第三次試運行,以進一步開發 REPELWRAP (TM) 薄膜
newsfile ·  01/24 19:00

Oakville, Ontario--(Newsfile Corp. - January 24, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX") a nanotechnology company developing surface protection coatings, is pleased to announce that the Company has entered into a third development stage agreement on January 23, 2024 with Dunmore International Corp. ("Dunmore"), a Steel Partners Holdings L.P. (NYSE: SPLP) operating company, for the Company to continue its development efforts to optimize the intermediate scale-up of REPELWRAP film and conduct a third manufacturing pilot run.

安大略省奧克維爾--(Newsfile Corp.,2024 年 1 月 24 日)-FendX Technologies Inc. (案例:FNDX)(OTCQB:FDXTF)(FSE:E8D) (那個”公司“或”FendX“)一家開發表面保護塗層的納米技術公司很高興地宣佈,該公司已於2024年1月23日與鄧莫爾國際公司簽訂了第三階段協議(”鄧莫爾“),一家運營公司Steel Partners Holdings L.P.(紐約證券交易所代碼:SPLP),要求該公司繼續開展開發工作,優化REPELWRAP薄膜的中間放大並進行第三次生產試點。

Dr. Carolyn Myers, CEO of FendX, states, "We are pleased with the progress we are making to advance the REPELWRAP film scale-up development with Dunmore. This third pilot manufacturing run will give us the opportunity to further refine the manufacturing process and we anticipate will bring us that much closer to conducting real-world environmental conditions testing." Dr. Myers continues, "We are very fortunate to have strong collaborations with Dunmore and McMaster University who have been instrumental in our achievements with REPELWRAP film to date."

FendX首席執行官卡羅琳·邁爾斯博士表示:“我們對與鄧莫爾一起推進REPELWRAP電影放大開發方面取得的進展感到滿意。第三次試點生產將使我們有機會進一步完善製造工藝,我們預計將使我們更接近於進行真實環境條件測試。”邁爾斯博士繼續說:“我們很幸運能與鄧莫爾和麥克馬斯特大學建立緊密的合作,他們對我們迄今爲止在REPELWRAP電影方面取得的成就發揮了重要作用。”

On October 3, 2023, the Company announced completion of its first pilot run on Dunmore's commercial manufacturing line that confirmed the REPELWRAP film formulation could be scaled-up to an intermediate-size and is suitable for automated manufacturing. On January 10, 2024, the Company announced it had completed its second pilot run. This run entailed combining the chemicals used to make REPELWRAP film to enable a one-pass process on the manufacturing equipment to reduce machine adjustments needed between each coating, as was the case with the first pilot run. The second pilot run confirmed the plastic film could be coated with a combined mixture and reduced the manufacturing time compared to the first pilot run, which supports the Company's ability to further advance and optimize the manufacturing process.

2023年10月3日,該公司宣佈完成其在鄧莫爾商業生產線上的首次試運行,這證實了REPELWRAP薄膜配方可以擴大到中等尺寸,適用於自動化製造。2024 年 1 月 10 日,該公司宣佈已完成第二次試運行。此次運行需要組合用於製作 REPELWRAP 薄膜的化學物質,從而在製造設備上實現一次性工藝,從而減少每次塗層之間所需的機器調整,就像第一次試運行一樣。第二次試運行證實,塑料薄膜可以塗覆複合混合物,與第一次試運行相比縮短了製造時間,這支持了公司進一步推進和優化製造過程的能力。

About Dunmore International Corp.

關於鄧莫爾國際公司

Dunmore is a global manufacturer of engineered coated and laminated films and foils with manufacturing facilities in the U.S. and Germany. Dunmore offers film conversion services such as coating, metallizing, and laminating along with contract film manufacturing and custom film product development. Dunmore services a diverse group of industries including aircraft, spacecraft, photovoltaic, graphic arts & labels, packaging, and insulation. Dunmore is a subsidiary of Steel Partners and is ISO 9001:2015 and OSHA VPP Star certified.

Dunmore是一家工程塗層和層壓薄膜和箔片的全球製造商,在美國和德國設有製造工廠。Dunmore 提供塗層、金屬化和層壓等薄膜轉換服務,以及合同薄膜製造和定製薄膜產品開發。Dunmore爲各種行業提供服務,包括飛機、航天器、光伏、平面藝術和標籤、包裝和絕緣。Dunmore 是 Steel Partners 的子公司,已獲得 ISO 9001:2015 和 OSHA VPP Star 認證。

About FendX Technologies Inc.

關於 FendX 科技公司

FendX is a Canada-based nanotechnology company focused on developing products to make people's lives safer by reducing the spread of pathogens. The Company is developing both film and spray products to protect surfaces from contamination. The lead product under development, REPELWRAP film, is a protective surface coating film that, due to its repelling properties, prevents the adhesion of pathogens and reduces their transmission on surfaces prone to contamination. The spray nanotechnology is a bifunctional spray coating being developed to reduce contamination on surfaces by repelling and killing pathogens. The Company is conducting research and development activities using its nanotechnology in collaboration with industry-leading partners, including McMaster University. The Company has an exclusive worldwide license to its technology and IP portfolio from McMaster, which encompass both film and spray coating nanotechnology formulations.

FendX 是一家總部位於加拿大的納米技術公司,專注於開發產品,通過減少病原體的傳播,使人們的生活更安全。該公司正在開發薄膜和噴霧產品,以保護表面免受污染。正在開發的主要產品 REPELWRAP 薄膜是一種保護性表面塗層薄膜,由於其排斥特性,它可以防止病原體粘附並減少其在易受污染的表面上的傳播。噴霧納米技術是一種雙功能噴塗塗層,正在開發中,通過排斥和殺死病原體來減少表面污染。該公司正在與包括麥克馬斯特大學在內的行業領先合作伙伴合作,利用其納米技術開展研發活動。該公司擁有麥克馬斯特的技術和知識產權組合的全球獨家許可,其中包括薄膜和噴塗塗層納米技術配方。

ON BEHALF OF THE BOARD

代表董事會

"Carolyn Myers"
Carolyn Myers
Chief Executive Officer and Director

卡羅琳·邁爾斯”
卡羅琳·邁爾斯
首席執行官兼董事

Contacts:
Dr. Carolyn Myers, CEO and Director
1-800-344-9868

聯繫人:
首席執行官兼董事卡羅琳·邁爾斯博士
1-800-344-9868

Alyssa Barry, Investor Relations
1-833-947-5227
investor@fendxtech.com

Alyssa Barry,投資者關係
1-833-947-5227
investor@fendxtech.com

For more information, please visit and the Company's profile on SEDAR+ at .

欲了解更多信息,請訪問SEDAR+上的公司簡介,網址爲。

Neither the Canadian Securities Exchange nor the Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

加拿大證券交易所和市場監管機構(該術語在加拿大證券交易所的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。

Forward-Looking Statements

前瞻性陳述

This news release contains certain forward-looking statements within the meaning of Canadian securities legislation, including with respect to: the plans of the Company; statements regarding further refining the manufacturing process; statements regarding getting closer to conducting real-world environment conditions testing; statements regarding the Company's scale-up and commercialization initiatives, milestones and intention to develop a commercial product; statements regarding conducting a third pilot run and further development and optimization of intermediate scale-up of REPELWRAP film; and products under development and any pathogen reduction benefits related thereto. Although the Company believes that such statements are reasonable, it can give no assurance that such expectations will prove to be correct. Forward-looking statements are statements that are not historical facts; they are generally, but not always, identified by the words "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "aims," "potential," "goal," "objective," "prospective," and similar expressions, or that events or conditions "will," "would," "may," "can," "could" or "should" occur, or are those statements, which, by their nature, refer to future events. The Company cautions that forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made and involve several risks and uncertainties. Consequently, there can be no assurances that such statements will prove to be accurate and that actual results and future events could differ materially from those anticipated in such statements.

本新聞稿包含加拿大證券立法所指的某些前瞻性陳述,包括:公司的計劃;關於進一步完善製造工藝的聲明;關於接近進行現實環境條件測試的聲明;有關公司擴大規模和商業化舉措、里程碑和開發商業產品的意向的聲明;有關進行第三次試運行以及進一步開發和優化的聲明REPELWRAP 薄膜的中期放大;以及正在開發的產品以及與之相關的任何病原體減少益處。儘管該公司認爲此類陳述是合理的,但它無法保證此類預期會被證明是正確的。前瞻性陳述是不是歷史事實的陳述;它們通常以 “期望”、“計劃”、“預期”、“相信”、“打算”、“估計”、“項目”、“目標”、“潛力”、“目標”、“目標”、“目標”、“前景” 和類似的表述來識別,或者事件或條件 “將”、“可能”、“可能”、“可能”、“可能”,“可能”,“可能”,“可能”,“可能”,“可能”,“可能”,“可能”,“可能”,“可能”,“可能”,“可能”,“可能”,“可能”,“可能”,“可能”,“可能”,” “可能” 或 “應該” 出現,或者這些言論,就其性質而言,是指未來的事件。公司警告說,前瞻性陳述基於公司管理層在陳述發表之日的信念、估計和觀點,涉及多種風險和不確定性。因此,無法保證此類陳述會被證明是準確的,也無法保證實際結果和未來事件可能與此類聲明中的預期有重大差異。

Important factors that could cause future results to differ materially from those anticipated in these forward-looking statements include: product candidates only being in formulation/reformulation stages; limited operating history; research and development activities; dependence on collaborative partners, licensors and others; effect of general economic and political conditions; and other risk factors set forth in the Company's public filings which are available on SEDAR+ at . Accordingly, the reader is urged to refer to the Company's such filings for a more complete discussion of such risk factors and their potential effects. Except to the extent required by applicable securities laws and the policies of the Canadian Securities Exchange, the Company undertakes no obligation to update these forward-looking statements if management's beliefs, estimates or opinions, or other factors should change.

可能導致未來業績與這些前瞻性陳述中的預期存在重大差異的重要因素包括:候選產品僅處於制定/重新制定階段;運營歷史有限;研發活動;對合作夥伴、許可方和其他人的依賴;總體經濟和政治狀況的影響;以及公司公開文件中列出的其他風險因素,這些文件可在SEDAR+上查閱。因此,我們敦促讀者參考公司的此類文件,以更全面地討論此類風險因素及其潛在影響。除非適用的證券法和加拿大證券交易所的政策有要求,否則如果管理層的信念、估計或觀點或其他因素髮生變化,公司沒有義務更新這些前瞻性陳述。

To view the source version of this press release, please visit

要查看本新聞稿的源版本,請訪問

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論